Imunon, Inc.
IMNN
$3.96
$0.051.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -270.95% | -1,773.98% | -755.99% | -25.70% | 55.15% |
| Gross Profit | 270.95% | 1,773.98% | 755.99% | 25.70% | -56.65% |
| SG&A Expenses | -12.30% | -13.90% | -7.62% | -23.09% | -29.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.63% | -19.48% | -10.27% | -9.02% | -5.25% |
| Operating Income | 30.63% | 19.48% | 10.27% | 9.02% | 4.71% |
| Income Before Tax | 30.88% | 18.68% | 11.62% | 10.46% | 29.55% |
| Income Tax Expenses | -- | -- | -- | -- | 18.29% |
| Earnings from Continuing Operations | 26.33% | 12.92% | 5.62% | 4.59% | 30.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.33% | 12.92% | 5.62% | 4.59% | 30.18% |
| EBIT | 30.63% | 19.48% | 10.27% | 9.02% | 4.71% |
| EBITDA | 30.94% | 19.58% | 10.25% | 9.09% | 4.85% |
| EPS Basic | 56.91% | 48.44% | 32.86% | 26.36% | 41.98% |
| Normalized Basic EPS | 59.88% | 51.85% | 36.03% | 29.60% | 17.69% |
| EPS Diluted | 56.91% | 48.44% | 32.86% | 26.36% | 41.98% |
| Normalized Diluted EPS | 59.88% | 51.85% | 36.03% | 29.60% | 17.69% |
| Average Basic Shares Outstanding | 92.40% | 73.13% | 48.20% | 38.53% | 26.83% |
| Average Diluted Shares Outstanding | 92.40% | 73.13% | 48.20% | 38.53% | 26.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |